Amazfit Announces the Bip 6 Smartwatch: The Everyday Smartwatch for Every Moment
Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch of the Amazfit Bip 6 smartwatch. Featuring a vibrant 1.97-inch AMOLED display, advanced health and heart rate monitoring, AI-powered fitness programs, offline navigation, and comprehensive sleep tracking, the Bip 6 is designed to support everyday fitness enthusiasts at each stage of their health journey.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250331697403/en/
Amazfit introduces Bip 6
Built for everyday durability, the Bip 6 features a sturdy aluminum alloy frame, 5 ATM water resistance, and an impressive two-week battery life. It comes in four stylish colorways—Black, Charcoal, Stone, and Red—all for just $79.99 USD.
“At Amazfit, we believe that technology—especially smart wearables—should enhance every aspect of life without compromising on style, performance, or affordability,” said Wayne Huang, founder & CEO, Zepp Health. “The Bip 6 was meticulously designed for those who need a smartwatch that keeps up with their active lifestyles while looking great. With advanced fitness tracking, intelligent coaching, and dedicated support for HYROX and endurance training, the Bip 6 adapts effortlessly to dynamic lifestyles while offering exceptional value.”
Key Features of the Amazfit Bip 6:
- Lightweight Aluminum Design with a Vibrant AMOLED Display
At 2,000 nits, the Bip 6’s 1.97-inch AMOLED screen is bright and easy to read in all lighting conditions. - Precise Heart Rate & Sleep Data Powered by BioTracker™ Technology
Equipped with Amazfit’s best-in-class BioTracker™ 6.0 PPG biometric dual-light 5PD heart rate sensor, the Bip 6 offers precise measurements for heart rate, blood oxygen levels, stress monitoring, HRV (heart rate variability) and more. - 140+ Workout Modes Including HYROX Race, Smart Strength Training, and Personalized AI Coaching
The Bip 6 supports over 140 fitness and lifestyle activities. Its Smart Strength Training feature provides detailed insights, such as automatic grouping of muscle exercises, while offline navigation with round-trip routing is great for outdoor enthusiasts. - Enhanced Battery Life
With a battery life of up to two weeks and 5 ATM water resistance, the Bip 6 can keep up with even the most active lifestyles. - Smart Features for Everyday Convenience
Receive on-wrist notifications for calls, texts, social media updates, calendar reminders, and more. Make and answer calls, reply to text messages using voice-to-text and the touch keyboard, control the camera (iPhone only) and music, sync notifications, and more—all through a Bluetooth connection to a phone. Zepp Flow™ provides full voice control of the watch, allowing users to adjust settings, view readiness scores, and more, without tapping, swiping, or memorizing keywords. - The Zepp App: Health and Fitness Tracking with Camera-Powered Food Log
The updated Zepp App offers a centralized, user-friendly platform for tracking health and fitness data, analyzing trends, and accessing personalized insights - with no mandatory subscriptions. A new food log feature allows users to photograph their meals directly in the app, automatically uploading nutrition data for seamless meal tracking. This feature is currently available in the United States, Canada, Germany, Spain, Italy, France, the UK and Japan.
Availability and Pricing
The Amazfit Bip 6 is available for purchase today on Amazfit.com and Amazon.Priced at $79.99 USD or €79.90 euro, the Bip 6 delivers premium features and performance at an unbeatable value.
For more information, please visit https://www.amazfit.com/en/ and follow us on Facebook, Instagram, X (formerly Twitter) and YouTube.
About Amazfit
Amazfit, a leading global smart wearable brand focused on health and fitness, is part of Zepp Health (NYSE: ZEPP), a health technology company. Offering a wide selection of smartwatches and bands, Amazfit's brand tagline "Discover Amazing", encourages individuals to break their barriers, and exceed expectations while finding joy in every moment.
Amazfit is powered by Zepp Health's proprietary health management platform that delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. With outstanding craftsmanship, Amazfit smartwatches have won many design awards, including the iF Design Award and the Red Dot Design Award.
Launched in 2015, Amazfit is today embraced by millions of users. Its products are available in more than 90 countries across the Americas, EMEA, and APAC regions. For more information about Amazfit, visit www.amazfit.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250331697403/en/
Contacts
Media Contact
Mary Woodbury
Head of PR, North America
Mary.woodbury@zepp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Frontgrade Gaisler Launches New GRAIN Line and Wins SNSA Contract to Commercialize First Energy-Efficient Neuromorphic AI for Space Applications2.4.2025 09:00:00 EEST | Press release
The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contract to commercialize the first neuromorphic System on Chip (SoC) device for space applications. Already in development at Frontgrade Gaisler, the device is part of the company’s new GRAIN (Gaisler Research Artificial Intelligence NOEL-V) product line. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401194593/en/ Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, has launched its new Gaisler Research Artificial Intelligence NOEL-V (GRAIN) product line. The first GRAIN device to premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI. The first GRAIN device that Frontgrade Gaisler will premiere –
Allshares Acquires Bolago to Strengthen Global Leadership and Expand Equity Management Offering2.4.2025 08:00:00 EEST | Press release
Allshares, a leading provider of equity and incentive management solutions, today announced the acquisition of Bolago, a company offering digital solutions for share programs, option schemes, and investments. The acquisition reinforces Allshares’ position as a leading global platform for end-to-end equity plan management and expands its capabilities in supporting growth-stage businesses and entrepreneurs. The deal follows Allshares’ recently announced accelerated growth strategy and builds on its global momentum. By integrating Bolago’s advanced technology for scenario planning and equity modeling, Allshares will broaden its product offering and further empower companies to manage incentive programs at scale. Hannes Rosén, CEO of Bolago, shared his excitement about the partnership: “Over the years, we’ve built a strong and diverse customer base and a talented team. Joining Allshares is a unique opportunity to elevate our service delivery with tech-forward compensation and equity softwa
Desentum Reports Strong Safety and Immunological Data From Phase 1 Clinical Study With Investigational Birch Pollen Allergy Vaccine DM-101PX2.4.2025 07:20:00 EEST | Press release
Desentum Oy, a clinical-stage biopharmaceutical company developing novel immunotherapies for treating allergies, announces positive clinical data with birch pollen allergy vaccine DM-101PX. The short-course treatment was found to be safe and well tolerated in birch pollen allergic patients and to induce a very strong and sustained allergen-specific IgG4 response. DM-101PX-induced immunoglobulins were found to efficiently block IgE-mediated basophil activation endorsing the product’s potential to induce a protective immune response. The randomised, double-blind, placebo-controlled study evaluated three dose escalation regimens, each consisting of ten subcutaneous injections over 10 weeks with DM-101PX or placebo in a total of thirty birch pollen allergic adults. No serious or severe adverse events occurred, and most adverse events were local injection-site reactions that are typically seen in subcutaneous allergen immunotherapy. Nearly all patients reached their targeted maximum dose. T
GE HealthCare and FPT Expand Strategic Partnership to Drive AI-Powered Healthcare Innovation2.4.2025 07:06:00 EEST | Press release
Global IT firm FPT and GE HealthCare announced a Strategic Cooperation Agreement, expanding their commercial alliance to advance product strategy and development, and establish an FPT Competency Center in Vietnam. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401306987/en/ This deepening collaboration reflects a strategic shift from project-based engagement to a long-term alliance aimed at accelerating the adoption of AI-driven solutions, enhancing operational efficiency, and improving patient care. As part of the commercial alliance, FPT will become a channel partner for GE HealthCare, jointly promoting and delivering GE HealthCare’s digital solutions in Vietnam and throughout its country network. FPT also plans on collaborating with GE HealthCare’s Science & Technology Office and affiliates to co-develop new and further develop GE HealthCare’s existing and new digital healthcare products. A key highlight of the partner
Former Mitsubishi IP Leader to Head Sisvel Japan2.4.2025 07:00:00 EEST | Press release
Yoshinori Shimizu has become managing director of the Japanese office of Sisvel, Europe’s biggest and longest-established patent pool operator. The appointment coincides with the retirement of Tetsuro Fuse, who will continue to work with Sisvel in an advisory capacity. Mr Shimizu is widely acknowledged as one of Japan’s leading IP professionals and most recently served as Deputy General Manager of the Corporate Export Control Division at Mitsubishi Electric Corporation, where he worked for 29 years. During his time at Mitsubishi, Mr Shimizu was instrumental in shaping the company’s global IP strategy, negotiating patent licensing agreements and resolving disputes. He has also played a key role in several patent pool initiatives, including those operated by Sisvel. As managing director of Sisvel Japan, Mr Shimizu will work closely with Sisvel’s global leadership team to drive the continued growth of the firm’s licensing programmes in Japan and across Asia. “Having worked with Sisvel as
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom